AMANDA JASPER: Open Payments
NPI 1164808036 · ATHENS, GA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$836 in 45 payments from 10 companies in 2025. Trend: 2023 $645 · 2024 $948 · 2025 $836
Food & beverage: $836
| Company | Payments | Amount |
|---|---|---|
| ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | 23 | $261 |
| Boston Scientific Corporation | 3 | $178 |
| Amgen Inc. | 6 | $115 |
| Edwards Lifesciences Corporation | 3 | $79 |
| ABIOMED | 2 | $49 |
| Bayer Healthcare Pharmaceuticals Inc. | 2 | $43 |
| Novartis Pharmaceuticals Corporation | 2 | $32 |
| AstraZeneca Pharmaceuticals LP | 2 | $31 |
| CVRx, Inc. | 1 | $29 |
| Chiesi USA, Inc. | 1 | $20 |
Products named: LifeVest, REPATHA, Rhythmia Mapping System, SAPIEN 3 Ultra RESILIA, BodyGuardian, Kerendia, LEQVIO, Barostim Neo System.
Industry payments across GA — which companies pay providers there.
